Medical Properties Trust has seen its share price under pressure in recent years, which puts a spotlight on whether the current US$3.01 level lines up with the cash it can realistically generate. The key issue for you is whether the stock price reflects those cash flows or is being driven mainly by sentiment around the real estate healthcare sector.
-
Over the past 5 years the stock has fallen 77.5%, which puts long term cash flow durability and the valuation that rests on it under close scrutiny.
-
For a real estate investment trust that relies on rental income and asset sales to fund operations and distributions, any shift in hospital tenant strength or funding access can materially affect the timing and reliability of future cash flows that underpin its worth.
-
Prefer to judge Medical Properties Trust on sales? See what Medical Properties Trust's 1.6x P/S says about the price .
The issue now is whether the cash flows that Medical Properties Trust can generate over time justify where the shares trade today.
To put Medical Properties Trust's cash flow question in context, it can help to compare it with other companies screened for 33 high quality undervalued stocks .
Is Medical Properties Trust a Bargain on Cash Flow?
The Discounted Cash Flow (DCF) model here looks at Medical Properties Trust through the cash it could return to shareholders over time. On this view, the trust generated about $183.9 million of free cash flow over the last twelve months, and the projections assume that adjusted funds from operations continue to build from this base rather than contract.
Forecast cash flows move into the $200 million range and then increase at gradually lower rates, which is consistent with a REIT that is expected to rely on hospital tenants stabilising rather than returning to rapid expansion. When those future streams are discounted back and compared with the current share price of $3.01, the DCF model indicates that Medical Properties Trust's estimated intrinsic value is substantially above where the stock trades today. Find out what Medical Properties Trust could be worth using our Discounted Cash Flow (DCF) estimate .
The Medical Properties Trust Narrative: What Would Justify Today's Price?
Narratives for Medical Properties Trust pick up where the DCF debate leaves off and spell out which paths for growth, margins and earnings would need to play out for the units to be worth meaningfully more or less than the current price, all housed on Simply Wall St's Community page. Each scenario ties its number to a concrete view of how Medical Properties Trust's cash generation, profitability profile and risk mix could evolve. This gives you a reference point to revisit as fresh information emerges.
One of the top community narratives on Medical Properties Trust: 56% undervalued
The main thing that has to go right is that re-tenanting outcomes such as HSA and NOR lease ramps, working capital loan recoveries, and behavioral health exposure collectively deliver the cash collections and asset values implied by current guidance and recent asset sale pricing...
Discover why this Narrative puts Medical Properties Trust at 56% undervalued .
Before acting on Medical Properties Trust's valuation, look at who is steering it
Price and cash flows tell only part of the story for Medical Properties Trust, because the people making capital decisions and how they are rewarded can tilt outcomes in ways the numbers here do not address. See who runs Medical Properties Trust and how they are paid .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include MPT .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
